Venous Thrombo-Embolism

New Trial Confirms Role For Pradaxa In Venous Thromboembolism
Forbes
Wed, 12/18/13 - 10:48 am
Venous Thrombo-Embolism
Pradaxa
bloodthinners
Boehringer Ingelheim
Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Reduction in Life-Threatening Venous Thrombo-Embolism
Yahoo/PR NewsWire
Sat, 06/4/11 - 10:29 am
Sanofi
Semuloparin
Venous Thrombo-Embolism